BackPLx Pharma Overview

PLx Pharma Receivables

Track PLx Pharma's receivables ($140K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$139000.00
95.73% YoYΔ $-3.11M vs prior year quarter

Peer trimmed avg / median

Loading

PLx Pharma Receivables History

Loading

PLx Pharma vs. peers: Receivables Comparison

Loading

PLx Pharma Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

PLx Pharma (PLXP) FAQ

The latest receivables for PLXP is $140K as of September 2022. That compares with $3.3M in the prior-year period — down 95.7% year over year. Investors often review this figure alongside PLx Pharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, PLXP's receivables moved from $3.3M to $140K — a 95.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in PLx Pharma's operating scale or balance-sheet position.

A receivables figure of $140K for PLXP is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PLXP's receivables ($140K), review year-over-year change from $3.3M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack PLx Pharma's receivables against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.